TOP TIERMARKET NEWSWIRE
News & sentiment

PALVELLA THERAPEUTIC (PVLA) — News & AI sentiment

PALVELLA THERAPEUTIC (PVLA) news roundup. 1 story in the past week, 7 over 30 days. Average 30-day sentiment is 56.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $1.6M — net selling of $1.6M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 50/100
30d stories
7
avg sentiment 56.7/100
Insider net (90d)
$1.6M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on PVLA

2d ago
H.C. Wainwright reiterates Palvella Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Jul 22
Jul 15
Jul 14
Jun 30
Jun 30
Jun 30
Jun 29
Jun 27
Jun 22
Jun 16
Jun 16
Jun 9
Jun 9
Jun 5
The Prognosis For Palvella Therapeutics
Seeking Alpha73 · bullishproduct/pr
Jun 3
Jun 3
Jun 2
May 27
May 21
May 20
May 20
Open PVLA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →